One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long ...

Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...

Please provide your email address to receive an email when new articles are posted on . Endologix announced that the FDA has granted approval of its percutaneous transmural arterial bypass system for ...

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...

For patients with a history of CABG surgery in need of a diagnostic catheterization and/or PCI, radial artery procedures are associated with a significantly lower risk of death, bleeding, and vascular ...

SEPSIS involving a vascular prosthesis, fortunately rare, is a most serious complication of arterial surgery. Although there are clinical and experimental examples of periprosthetic sepsis that have ...